5-Alkyl 1,2-dihydrochromeno[3,4-f]quinolines: a novel class of nonsteroidal progesterone receptor modulators
Graphic
References (17)
- et al.
Tetrahedron Lett.
(1984) - et al.
Mol. Endocrinol.
(1991) - et al.
J. Steriod Biochem. Molec. Biol.
(1991) - et al.
J. Med. Chem.
(1998) - et al.
J. Med. Chem.
(1998) - et al.
J. Med. Chem.
(1998) - et al.
Mol. Pharm.
(1995) - et al.
J. Med. Chem.
(1995)
There are more references available in the full text version of this article.
Cited by (24)
6H-Benzo[c]chromen-6-one derivatives as selective ERβ agonists
2006, Bioorganic and Medicinal Chemistry LettersTrifluoromethyl group as a pharmacophore: Effect of replacing a CF <inf>3</inf> group on binding and agonist activity of a glucocorticoid receptor ligand
2005, Bioorganic and Medicinal Chemistry LettersDifferentiation of in vitro transcriptional repression and activation profiles of selective glucocorticoid modulators
2004, Bioorganic and Medicinal Chemistry LettersDevelopment of progesterone receptor antagonists from 1,2-dihydrochromeno[3,4-f]quinoline agonist pharmacophore
2003, Bioorganic and Medicinal Chemistry LettersSynthesis and biological activity of 5-methylidene 1,2-dihydrochromeno[3,4-f]quinoline derivatives as progesterone receptor modulators
2003, Bioorganic and Medicinal Chemistry LettersAryllead triacetates in the synthesis of oxaphenanthrene derivatives
2001, Tetrahedron Letters
- 1
Current address: Ontogene Corporation, 6451 El Camino Real, Carlsbad, CA92009.
Copyright © 1998 Published by Elsevier Ltd.